In vitro effects of fenretinide on cell-matrix interactions

Anticancer Research

Volumn 20, Issue 5, 2000, Pages 3059-3066

  Vaccari, M ^a   Silingardi, P ^a   Argnani, A ^a   Horn, W ^a   Giungi, M ^a   Mascolo, M G ^a   Grilli, S ^a   Colacci, A ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Adhesion; Chemoprevention; Fenretinide; Invasion; Migration

Indexed keywords

COLLAGEN TYPE 4; FENRETINIDE; FIBRONECTIN; LAMININ; RETINOIC ACID DERIVATIVE; RETINOID; VITRONECTIN;

ANGIOGENESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOMA IN SITU; CELL ADHESION; CELL DIFFERENTIATION; CELL INTERACTION; CELL MOTILITY; CELL PROLIFERATION; CELL TRANSFORMATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG MECHANISM; EXTRACELLULAR MATRIX; IN VITRO STUDY; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TUMOR GROWTH; ZYMOGRAPHY;

3T3 CELLS; ANIMALS; ANTICARCINOGENIC AGENTS; BIOCOMPATIBLE MATERIALS; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; CHEMOTAXIS; COLLAGEN; DRUG COMBINATIONS; EXTRACELLULAR MATRIX; FENRETINIDE; GELATINASES; LAMININ; MATRIX METALLOPROTEINASE 2; MICE; PROTEOGLYCANS;

EID: 0033794633     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. A rapid in vitro assay for quantitating the invasive potential of tumor cells
2. Tumor and endothelial cell invasion of basement membrane
3. Retinoids in cancer chemoprevention
4. Chemoprevention of cancer with retinoids
5. N-(4-hydroxyphenyl)retinamide, a new retinoid for the prevention of breast cancer in the rat
6. Bioactivities of N-(4-hydroxyphenyl) retinamide and retinoyl-glucuronide
7. Chemopreventive efficacy of combined retinoid and tamoxifen treatment following surgical excision of a primary mammary cancer in female rats
8. Synthetic retinoid fenretinide is effective against a human ovarian carcinoma xenograft and potentiates cisplatin activity
9. Can fenretinide protect woman against ovarian cancer?
10. Chemoprevention of breast cancer with fenretinide
11. Clinical development plan: N-(4-hydroxyphenyl) retinamide (4-HPR)
12. Induction of chemotactic and invasive phenotype in BALB/c 3T3 cells by 1,2-dibromoethane transformation
13. Effects of the protease inhibitor antipain on cell malignant transformation
14. Retinoic acid modulates attachment of mouse fibroblasts to laminin substrates
15. Expression of β1 integrin in laminin-adhesion-selected human colon cancer cell lines of varying tumorigenicity
16. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates
17. N-(4-hydroxyphenyl)retinamide derivatives in rodents
18. Five-year administration of fenretinamide: Pharmacokinetics and effect on plasma retinol concentration
19. Transforming activity of ethylene dibromide in BALB/c 3T3
20. In vitro anti-invasive effect of N-(4-hydroxyphenyl)-retinamide on human prostatic adenocarcinoma
21. Biology and biochemistry of proteinases in tumor invasion
22. Changing views of the role of matrix matalloproteinases in metastasis
23. Differential effects of retinoic acid (RA) and N-(4-hydroxyphenyl)retinamide (4-HPR) on cell growth, induction of differentiation, and changes in p34cdc2, Bcl-2, and actin expression in the human promyelocytic HL-60 leukemic cells
24. Treatment of prostate cancer in the rat with the synthetic retinoid fenretinide
25. Modulation of the malignant phenotype of human prostate cancer cells by N-(4-hydroxyphenyl)retinamide (4-HPR)
26. Induction of apoptosis by fenretinide (4-HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression
27. 4-Hydroxyphenyl retinamide is a highly selective activator of retinoid receptors
28. Inhibition of cancer cell growth by all-trans retinoic acid and its analog n-(4-hydroxyphenyl) retinamide: A possible mechanism of action via regulation of retinoid acid receptors expression
29. Retinoic acid receptor expression and growth inhibition of gynecologic cancer cell by the synthetic retinoid N-(4-hydroxyphenil) retinamide
30. N-(4-hydroxyphenyl) retinamide (4-HPR) mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma
31. N-(4-Hydroxyphenyl)retinamide activation of a distinct pathway signaling apoptosis
32. Involvement of reactive oxigen species in N-(4-hydroxyphenyl) retinamide-induced apoptosis in cervical carcinoma cells
33. Retinoid receptor-dependent and -independent effects of N-(4-hydroxyphenyl)retinamide in F9 embrional carcinoma cells
34. Retinoic acid and 4-hydroxyphenylretinamide induce growth inhibition and tissue transglutaminase through different signal transduction pathways in mouse fibroblasts (NIH 3T3 cells)
35. Integrin signaling and cell growth control
36. Integrins and cancer
37. Cytoskeletal and adhesion proteins as tumor suppressors
38. Retinoic acid inhibition of human melanoma cell invasion through a reconstituted basement membrane and its relation to decreases in the expression of proteolytic enzymes and motility factor receptor
39. Retinoids and cell adhesion
40. Use of the membrane invasion culture system (MICS) as a screen for anti-invasive agents
41. Regulation of vitronectin receptor expression by retinoic acid on human melanoma cells
42. Modulation of markers associated with tumor aggressiveness in human breast cancer cell lines by N-(4-hydroxyphenil)retinamide
43. Induction of apoptosis in human neuroblastoma cells by abrogation of integrin-mediated cell adhesion